BreathDirect Ventilator Authorized by FDA
The BDR-19 critical care ventilator has received emergency use authorization from the US FDA, according to Nectar Product Development and BreathDirect.
The BDR-19 critical care ventilator has received emergency use authorization from the US FDA, according to Nectar Product Development and BreathDirect.
The BDR-19 critical care ventilator has received emergency use authorization from the US FDA, according to Nectar Product Development and BreathDirect.
Read MoreThe BDR-19, a low-cost, full-service ventilator from BreathDirect, was determined by Underwriters Laboratory to meet necessary criteria as an emergency use ventilator to treat ventilatory insufficiency.
Read MoreBreathDirect, a California-based medical device company, is developing a low-cost, critical care ventilator with a comprehensive set of operating modes and ranges designed in response to COVID-19.
Read More